CCI CNAMBFree Certified Ambulatory Surgery Nurse practice test

Correct answer: B. Use a trained, qualified medical interpreter instead of a family member for the consent discussion

Federal law (Title VI of the Civil Rights Act) and Joint Commission standards require healthcare organizations to provide qualified medical interpreters at no cost to patients with limited English proficiency; using a family member for high-stakes communications such as informed consent is strongly discouraged because family interpreters may omit, alter, or editorialize clinical information and cannot be held to professional standards of accuracy or confidentiality. Using written translated materials alone (C) does not allow for questions or verification of understanding. Delaying the procedure (D) is unnecessary and places an unfair burden on the patient.

Correct answer: B. Write down the order, read it back verbatim to the surgeon, receive confirmation, then enter and execute the order

Closed-loop communication for verbal orders requires the receiver to write the order, read it back completely to the ordering provider, and obtain explicit confirmation before executing the order — this is the read-back/verify standard endorsed by The Joint Commission NPSG.02.03.01. Simply entering the order without read-back (A) bypasses the verification step that catches transcription errors. Delegating verbal-order acceptance to the anesthesia provider (C) is not a standard practice and does not remove the nurse's accountability. Administering blood without any preliminary documentation or verification (D) violates both safe administration and documentation standards even in emergent situations.

Correct answer: B. Stop the briefing, notify the surgeon immediately, and clarify the discrepancy with the patient and the surgical team before any further preparation

Any discrepancy identified during site marking or the briefing represents a critical safety concern that requires an immediate stop-the-line response consistent with Universal Protocol (Joint Commission). The entire team must resolve the discrepancy — by reviewing the consent, imaging, and re-interviewing the patient — before the procedure can advance; the consent form alone does not override a patient's verbal identification of the site. Proceeding on the basis of the written consent (A) ignores the patient's direct input and risks wrong-site surgery. Documenting without halting (C) or delegating clarification to an off-site nurse (D) both allow the team to continue toward a preventable sentinel event.

Correct answer: B. Ask the patient to teach back the eye drop schedule and instillation technique in their own words

The teach-back method, in which the clinician asks the patient to explain or demonstrate the information in their own words, is the evidence-based standard for verifying health literacy comprehension and is endorsed by AORN, ASPAN, and health literacy best-practice guidelines. Simply agreeing verbally ("yes") or possessing written materials (A, D) does not confirm understanding. Teach-back actively identifies gaps so re-instruction can occur before discharge. Referring to a primary care physician (C) shifts responsibility away from the discharging nurse and does not resolve the immediate knowledge deficit.

Correct answer: C. Situation: the patient's name, procedure performed, anesthetic used, and current status

SBAR (Situation, Background, Assessment, Recommendation) is a structured handoff communication framework; Situation is always presented first because it orients the receiving provider to who the patient is, what was done, and the patient's immediate status — information the PACU nurse needs before any other context. Background (A) follows Situation and provides historical context. Assessment (D) comes third to relay intraoperative findings. Recommendation (B) is the final element, offering follow-up guidance. Transmitting these elements out of order can obscure the most time-critical information.

Correct answer: A. Notify the device manufacturer of the implant and document the device's unique device identifier (UDI), lot/serial number, and patient contact information in the implant log

FDA 21 CFR Part 821 requires manufacturers AND device-user facilities (including ASCs) to establish and maintain tracking systems for Class II and Class III tracked devices such as implantable neurostimulators. The facility must record the UDI, lot/serial number, and patient identifying information and ensure this data is communicated to the manufacturer to enable rapid recall notification. Applying a sticker to the operative note without registry notification (B) is incomplete. Implant tracking is a facility obligation, not solely the surgeon's (C). Deferring regulatory documentation to a post-op visit (D) violates the requirement that tracking occur at the point of implantation.

Correct answer: B. The original nurse's method — single line-through, correction, initials, and date — is the correct approach; altering or obliterating entries is legally impermissible

Legal standards for medical record correction require that the original entry remain legible; the standard method is a single line drawn through the error so the original text can still be read, followed by the correct information, the corrector's initials, and the date. Using correction fluid or otherwise obliterating an original entry (A) constitutes falsification of a legal document and can void the entire record's credibility in litigation. Voiding and rewriting the page (C) destroys the original record. Transferring paper entries to an EHR and editing freely (D) conflates two separate documentation systems and introduces chain-of-custody issues.

Correct answer: B. Confirm that only the information reasonably necessary to accomplish the pre-authorization — such as the operative note and relevant diagnoses — is disclosed, and transmit via a secure, encrypted channel

HIPAA's minimum necessary standard (45 CFR §164.502(b)) requires covered entities to make reasonable efforts to limit PHI disclosures to the minimum amount needed to accomplish the intended purpose; a pre-authorization request does not require the patient's complete financial history, and transmitting the full chart violates this principle. Treatment purposes do permit broader disclosure, but minimum necessary still applies to disclosures to other covered entities for non-direct-treatment activities such as insurance coordination (A is incorrect). Completely refusing the release (C) is an overcorrection — appropriate PHI sharing for treatment-adjacent purposes is permitted. Delegating the decision entirely to a billing coordinator (D) does not absolve the nurse from professional and regulatory accountability for PHI handling.

Correct answer: B. Discontinue the triggering agent and administer dantrolene 2.5 mg/kg IV as rapidly as possible

Dantrolene 2.5 mg/kg IV is the specific antidote for malignant hyperthermia; it blocks calcium release from the sarcoplasmic reticulum, directly halting the hypermetabolic crisis, and must be given without delay after all triggering agents (volatile anesthetics, succinylcholine) are discontinued. Sodium bicarbonate may be given as an adjunct for severe metabolic acidosis but is not the priority over dantrolene. Active cooling measures are supportive and secondary to dantrolene administration. Obtaining a 12-lead ECG before giving dantrolene wastes critical time; hyperkalemia is managed concurrently but must not delay the antidote.

Correct answer: B. Epinephrine 0.3–0.5 mg (1:1,000) intramuscularly into the lateral thigh

Epinephrine 0.3–0.5 mg of 1:1,000 solution IM into the vastus lateralis (lateral thigh) is the definitive first-line treatment for anaphylaxis per current AAAAI/ACAAI and WAO guidelines; it reverses bronchospasm, vasodilation, and laryngeal edema simultaneously. IM delivery into the lateral thigh achieves peak plasma concentration more rapidly than subcutaneous injection, and even in settings with IV access the IM dose is given first while preparations for IV epinephrine infusion proceed if needed. Diphenhydramine and corticosteroids are adjuncts that do not reverse the acute hemodynamic collapse and airway compromise; they must never precede or replace epinephrine. Inhaled albuterol addresses only the bronchospasm component and has no effect on hypotension or airway edema.